The electrophysiology of prefrontal serotonin systems: Therapeutic implications for mood and psychosis

Biological Psychiatry

Volumn 44, Issue 11, 1998, Pages 1118-1127

  Marek, Gerard J ^a   Aghajanian, George K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Asynchronous release; Depression; Glutamate; Medial prefrontal cortex; Schizophrenia; Serotonin(2A) receptor

Indexed keywords

GLUTAMIC ACID; PSYCHEDELIC AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR;

DEPRESSION; EXCITATORY POSTSYNAPTIC POTENTIAL; HALLUCINATION; HUMAN; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM;

ANTIPSYCHOTIC AGENTS; ELECTRIC STIMULATION; GLUTAMATES; HUMANS; MOOD DISORDERS; NEURONS, EFFERENT; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; PYRAMIDAL CELLS; RECEPTORS, SEROTONIN; SEROTONIN; SYNAPSES;

EID: 0032402426     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00036-5     Document Type: Review

References (78)

1. Aghajanian G.K. Electrophysiology of serotonin receptor subtypes and signal transduction mechanisms. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation of Progress . 1995;451-460 Raven Press, New York.
2. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology. 36:1997;589-599.
3. Altar C.A., Wasley A.M., Neale R.F., Stone G.A. Typical and atypical antipsychotic occupancy of D2 and S2 receptors An autoradiographic analysis in rat brain . Brain Res Bull. 16:1986;517-525.
4. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
5. Blue M.E., Yagaloff K.A., Mamounas L.A., Hartig P.R., Molliver M.E. Brain Res. 453:1988;315-328.
6. Bodkin J.A., Zornberg G.L., Lukas S.E., Cole J.O. Buprenorphine treatment of refractory depression. J Clin Psychopharmacol. 15:1995;49-57.
7. Bouron A., Reuter H. A role of intracellular Na+ in the regulation of synaptic transmission and turnover of the vesicular pool in cultured hippocampal cells. Neuron. 17:1996;969-978.
8. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia. Neuropsychopharmacology. 15:1996;442-455.
9. Carlson E.T., Simpson M.M. Opium as a tranquilizer. Am J Psychiatry. 120:1963;112-117.
10. Cleghorn J.M., Garnett E.S., Nahmias C., et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenics. Psychiatry Res. 28:1989;119-133.
11. Comfort A. Morphine as an antipsychotic? Clin Tox. 11:1977;383-386.
12. Cummings D.D., Wilcox K.S., Dichter M.A. Calcium-dependent paired-pulse facilitation of miniature EPSC frequency accompanies depression of EPSCs at hippocampal synapses in culture. J Neurosci. 16:1996;5312-5323.
13. de Boer T. The pharmacologic profile of mirtazepine. J Clin Psychiatry. 57:1996;19-25.
14. Delphs J.M., Kong H., Mestek A., et al. Expression of mu opioid receptor mRNA in rat brain An in situ hybridization study at the single cell level . J Comp Neurol. 345:1994;46-68.
15. Drevets W.C., Price J.L., Simpson J.R.J., et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 386:1997;824-827.
16. Dwight M.M., Keck P.E., Stanton S.P., Strakowski S.M., McElroy S.L. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet. 344:1994;554-555.
17. Ebmeier K.P., Blackwood D.H.R., Murray C., et al. Single-photon emission computed tomography with [99m]Tc-exametazime in unmedicated schizophrenic patients. Biol Psychiatry. 33:1993;487-495.
18. Eison A.S., Eison M.S., Torrente J.R., Wright R.N., Yocca F.D. Nefazodone Preclinical pharmacology of a new antidepressant . Psychopharmacol Bull. 26:1990;311-315.
19. Felder C.C., Kanterman R.Y., Ma A.L., Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci USA. 87:1990;2187-2191.
20. h Intracellular studies in rat facial motoneurons . Synapse. 13:1993;123-134.
21. Gellman R.L., Aghajanian G.K. Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons. Brain Res. 600:1993;63-73.
22. 2 receptor-mediated excitation of interneurons in pirform cortex Antagonism by atypical antipsychotic drugs . Neuroscience. 58:1994;515-525.
23. Geppert M., Goda Y., Hammer R.E., et al. Synaptotagmin I A major Ca2+ sensor for transmitter release at a central synapse . Cell. 79:1994;717-727.
24. Gleason E., Borges S., Wilson M. Control of transmitter release from retinal amacrine cells by Ca2+ influx and efflux. Neuron. 13:1994;1109-1117.
25. 2 involvement in the mechanism of action of hallucinogenic agents. Life Sci. 35:1984;2502-2511.
26. Goda Y., Stevens C.F. Two components of transmitter release at a central synapse. Proc Natl Acad Sci USA. 91:1994;12942-12946.
27. Gold M.S., Donabedian R.K., Dillard M., Slobetz F.W., Riordan C.E., Kleber H.D. Antipsychotic effect of opiate agonists. Lancet. ii:1977;398-399.
28. Gold M.S., Pottash A.L.C., Sweeney D.R., Kleber H.D., Redmond D.E.J. Rapid opiate detoxification Clinical evidence of antidepressant and antipanic effects of opiates . Am J Psychiatry. 136:1979;982-983.
29. Gurevich E.V., Joyce J.N. Alteration in the cortical serotonergic system in schizophrenia A postmortem study . Biol Psychiatry. 42:1997;529-545.
30. Hermle L., Funfgeld M., Oepen G., et al. Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects Experimental psychosis as a tool for psychiatric research . Biol Psychiatry. 32:1992;976-991.
31. Hoyer D., Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res. 376:1986;97-107.
32. Hubel D.H., Wiesel T.N. Functional architecture of macaque monkey visual cortex (Ferrier lecture). Proc R Soc Lond Biol Sci. 198:1977;1-59.
33. Jakab R.L., Goldman-Rakic P.S. 5-HT2A serotonin receptors in the primate cerebral cortex Possible site of action of hallucinogens in pyramidal cell apical dendrites . Proc Natl Acad Sci USA. 95:1998;735-740.
34. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry. 45:1988;789-796.
35. Kanof P.D., Aronson M.J., Ness R. Organic mood syndrome associated with detoxification from methadone maintenance. Am J Psychiatry. 150:1993;423-428.
36. Kaplan R.D., Szechtman H., Franco S., et al. Three clinical syndromes of schizophrenia in untreated subjects Relation to glucose activity measured by positron emission tomography (PET) . Schizoph Res. 11:1993;47-54.
37. Katz B., Miledi R. The effect of calcium on acetylcholine release from motor nerve terminals. Proc R Soc London B Biol Sci. 161:1965;483-495.
38. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther. 277:1996;968-981.
39. Kraepelin E. Manic-Depressive Insanity and Paranoia. 1921;E & S Livingstone, Edinburgh.
40. Krystal J.H., Karper L.P., Seibyl J.P., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry. 51:1994;199-214.
41. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
42. Li C., Davletov B.A., Sudhof T.C. Distinct Ca2+ and Sr2+ binding properties of synaptotagmins Definition of candidate Ca2+ sensors for the fast and slow components of neurotransmitter release . J Biol Chem. 270:1995;24898-24902.
43. Luther P.W., Yip R.K., Bloch R.J., Ambesi A., Lindenmayer G.E., Blaustein M.P. Presynaptic localization of sodium/calcium exchangers in neuromuscular preparations. J Neurosci. 12:1992;4898-4904.
44. Ma J.Y., Catterall W.A., Scheuer T. Persistent sodium currents through brain sodium channels induced by G protein beta-gamma subunits. Neuron. 19:1997;443-452.
45. 2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry. 43:1986;954-959.
46. Mansour A., Fox C.A., Burke S., et al. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS An in situ hybridization study . J Comp Neurol. 350:1994;412-438.
47. Mansour A., Fox C.A., Thompson R.A., Akil H., Watson S.J. μ-Opioid receptor mRNA expression in the rat CNS Comparison to μ-receptor binding . Brain Res. 643:1994;245-265.
48. 2A receptor antagonist . Eur J Pharmacol. 259:1994;137-141.
49. 2A receptor-mediated excitatory effects of serotonin on interneurons in rat piriform cortex. Synapse. 21:1995;123-130.
50. 2A receptors on neurons in the rat piriform cortex. J Pharmacol Exp Ther. 278:1996;1373-1382.
51. Marek G.J., Aghajanian G.K. Serotonin-2A receptor induced EPSCs in apical dendrites of layer V pyramidal cells of prefrontal cortex Block by μ-opiate receptor agonists . Soc Neurosci Abstr. 23:1997;974.
52. Marek GJ, Aghajanian GK (in press): 5-HT-induced EPSCs in neocortical layer V pyramidal cells: Suppression by μ-opiate receptor activation. Neuroscience.
53. Marek G.J., McDougle C.J., Price L.H., Seiden L.S. A comparison of trazodone and fluoxetine Implications for a serotonergic mechanism of antidepressant action . Psychopharmacology. 109:1992;2-11.
54. Matsuda T., Takuma K., Baba A. Na+-Ca2+ exchanger Physiology and pharmacology . Jpn J Pharmacol. 74:1997;1-20.
55. Mayberg H.S., Brannan S.K., Mahurin R.K., et al. Cingulate function in depression A potential predictor of treatment response . Neuroreport. 8:1997;1057-1061.
56. i values. J Pharmacol Exp Ther. 251:1989;238-246.
57. O'Brien C.P., Woody G.E., McLellan A.T. Psychiatric disorders in opioid-dependent patients. J Clin Psychiatry. 45:1984;9-13.
58. Parellada E., Catafau A.M., Bernardo M., Lomena F., Gonzalez-Monclus E., Setoain J. Prefrontal dysfunction in young acute neuroleptic-naive schizophrenic patients A resting and activation SPECT study . Psychiatry Res Neuroimaging. 55:1994;131-139.
59. 2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide. J Pharmacol Exp Ther. 247:1988;918-925.
60. Powell T.P.S., Mountcastle V.B. Some aspects of the functional organization of the neocortex of the postcentral gyrus of the monkey A correlation of findings obtained in a single unit analysis with cytoarchitecture . Bull Johns Hopkins Hosp. 105:1959;133-162.
61. 2A binding affinity. Neuropsychopharmacology. 1:1988;101-107.
62. 2A binding affinity . Eur J Pharmacol. 132:1986;79-82.
63. Sanders-Bush E., Burris K.D., Knoth K. Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis. J Pharmacol Exp Ther. 246:1988;924-928.
64. Schaffer C.B., Schaffer L.C. The use of risperidone in the treatment of bipolar disorder. J Clin Psychiatry. 57:1996;136.
65. Schnierow B.J., Graeber D.A. Manic symptoms associated with initiation of risperidone. Am J Psychiatry. 153:1996;1235-1236.
66. Schreiber R., Brocco M., Millan M.J. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the "atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol. 264:1994;99-102.
67. 2A-activated interneuron . Brain Res. 506:1990;62-69.
68. 2 receptors in interneurons . Synapse. 9:1991;208-218.
69. Stafstrom C.E., Schwindt P.C., Chubb M.C., Crill W.E. Properties of persistent sodium conductance and calcium conductance of layer V neurons from cat sensorimotor cortex in vitro. J Neurophysiol. 53:1985;153-170.
70. Stockmeier C.A., Dilley G.E., Shapiro L.A., Overholser J.C., Thompson P.A., Meltzer H.Y. Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 16:1997;162-173.
71. Tanaka E., North R.A. Actions of 5-hydroxytryptamine on neurons of the rat cingulate cortex. J Neurophysiol. 69:1993;1749-1757.
72. 2+ and glutamate release . J Neurochem. 53:1989;1693-1699.
73. 2 receptor as a site of action for LSD and phenethylamine hallucinogens. Psychopharmacology (Berl). 94:1988;213-216.
74. Vollenweider F.X., Leenders K.L., Scharfetter C., et al. Metabolic hyerfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F] fluorodeoxyglucose (FDG). Eur Neuropsychopharmacol. 7:1997;9-24.
75. Vollenweider F.X., Leenders K.L., Scharfetter C., Maguire P., Stadelmann O., Angst J. Positron emission tomography and fluorodeoxyglucose studies of metabolic hyerfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharmacology. 16:1997;357-372.
76. Willins D.L., Deutch A.Y., Roth B.L. Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse. 27:1997;79-82.
77. 2 receptor changes in major depression. Biol Psychiatry. 27:1990;489-496.
78. Zhang Z.-W., Deschenes M. Intracortical axonal projections of lamina VI cells of the primary somatosensory cortex in the rat A single cell labeling study . J Neurosci. 17:1997;6365-6379.